Literature DB >> 26045759

Radiotherapy suppressed tumor-specific recruitment of regulator T cells via up-regulating microR-545 in Lewis lung carcinoma cells.

Chen Liao1, Wei Xiao1, Nuo Zhu1, Zhiyuan Liu1, Jiu Yang1, Yanhu Wang1, Mei Hong1.   

Abstract

OBJECTIVE: Radiotherapy is an important treatment for cancer. The main irradiated action is thought to be the irreversible damage to tumor cell DNA, but recent studies showed that high dose radiotherapy related to the tumor immune response. This study was designed to determine the relationship between Lewis lung tumor radiosensitivity and CD4+CD25+ regulatory T cells (Tregs) infiltration and elucidate the underlying mechanisms in vitro.
METHODS: With tumor transplantation method to establish mice Lewis lung tumor mice model, to observe the inhibition rate of radiotherapy to tumor growth. Proliferation profiles of CD4+CD25+ Tregs and CD4+ T cells were assessed by flow cytometry. MiR-545 and CCL-22 mRNA were determined by Quantitative Real-Time PCR. CCL-22 protein was determined by western blot assay.
RESULTS: Radiotherapy caused a time-dependent inhibition of tumor growth as well as a decrease in the percentage of tumor-infiltrating CD4+CD25+ Tregs of CD4+ T cells compared with no treatment group. And the miR-545 was significantly upregulated and CCL-22 was significantly down-regulated in irradiated tumor and Lewis lung cancer cells. In Lewis lung cancer cell transfection experiments, mimic or inhibitor for miR-545 negatively regulated CCL-22 expression when cells treated or treated without irradiation. Silenced miR-545 promotes CD4+CD25+ Treg proliferation. Additionally, silenced miR-545 reversed radiosensitivity of Lewis lung cancer.
CONCLUSION: Radiotherapy suppressed specific recruitment of regulator CD4+CD25+ Treg cells in Lewis lung carcinoma via up-regulating microR-545.

Entities:  

Keywords:  CCL-22; CD4+CD25+ T regulator cells; Lewis lung cancer cells; miR-545; radiotherapy; tumor xenograft

Mesh:

Substances:

Year:  2015        PMID: 26045759      PMCID: PMC4440068     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

1.  Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance.

Authors:  Gang Zhou; Hyam I Levitsky
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

Review 2.  Natural selection of tumor variants in the generation of "tumor escape" phenotypes.

Authors:  Hung T Khong; Nicholas P Restifo
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

Review 3.  Immunodominance and tumor escape.

Authors:  H Schreiber; T H Wu; J Nachman; W M Kast
Journal:  Semin Cancer Biol       Date:  2002-02       Impact factor: 15.707

4.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

5.  Immunobiology of radiotherapy: new paradigms.

Authors:  Mansoor M Ahmed; Chandan Guha; James W Hodge; Elizabeth Jaffee
Journal:  Radiat Res       Date:  2014-07-18       Impact factor: 2.841

Review 6.  Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer.

Authors:  R E Roses; M Xu; G K Koski; B J Czerniecki
Journal:  Oncogene       Date:  2008-01-07       Impact factor: 9.867

7.  Lung Cancer: Are we up to the Challenge?

Authors:  Luca Esposito; Daniele Conti; Ramyasri Ailavajhala; Nansie Khalil; Antonio Giordano
Journal:  Curr Genomics       Date:  2010-11       Impact factor: 2.236

8.  Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

Authors:  M K Levings; R Sangregorio; M G Roncarolo
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

9.  CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade.

Authors:  P A Taylor; R J Noelle; B R Blazar
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

Review 10.  T-regulatory cell modulation: the future of cancer immunotherapy?

Authors:  S Nizar; J Copier; B Meyer; M Bodman-Smith; C Galustian; D Kumar; A Dalgleish
Journal:  Br J Cancer       Date:  2009-04-21       Impact factor: 7.640

View more
  8 in total

1.  Autophagy inhibition upregulates CD4+ tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activation.

Authors:  Paul Zarogoulidis; Savvas Petanidis; Kalliopi Domvri; Efrosini Kioseoglou; Doxakis Anestakis; Lutz Freitag; Konstantinos Zarogoulidis; Wolfgang Hohenforst-Schmidt; Wilfried Eberhardt
Journal:  Mol Oncol       Date:  2016-09-16       Impact factor: 6.603

2.  Heterogeneity of circulating tumor cell dissemination and lung metastases in a subcutaneous Lewis lung carcinoma model.

Authors:  Jessica E Fitzgerald; Brook K Byrd; Roshani A Patil; Rendall R Strawbridge; Scott C Davis; Chiara Bellini; Mark Niedre
Journal:  Biomed Opt Express       Date:  2020-06-08       Impact factor: 3.732

Review 3.  Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.

Authors:  Yingying Xing; Guojing Ruan; Haiwei Ni; Hai Qin; Simiao Chen; Xinyue Gu; Jiamin Shang; Yantong Zhou; Xi Tao; Lufeng Zheng
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

Review 4.  Modulation of CD4 T Cell Response According to Tumor Cytokine Microenvironment.

Authors:  Théo Accogli; Mélanie Bruchard; Frédérique Végran
Journal:  Cancers (Basel)       Date:  2021-01-20       Impact factor: 6.639

Review 5.  Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy.

Authors:  Laura A Huppert; Michael D Green; Luke Kim; Christine Chow; Yan Leyfman; Adil I Daud; James C Lee
Journal:  Cell Mol Immunol       Date:  2021-08-20       Impact factor: 11.530

6.  Blocking circ_0014130 suppressed drug resistance and malignant behaviors of docetaxel resistance-acquired NSCLC cells via regulating miR-545-3p-YAP1 axis.

Authors:  Dongjie Du; Xiaoci Cao; Xinbo Duan; Xianbo Zhang
Journal:  Cytotechnology       Date:  2021-05-25       Impact factor: 2.040

7.  Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma.

Authors:  Zhikui Liu; Changwei Dou; Bowen Yao; Meng Xu; Linglong Ding; Yufeng Wang; Yuli Jia; Qing Li; Hongyong Zhang; Kangsheng Tu; Tao Song; Qingguang Liu
Journal:  Oncotarget       Date:  2016-05-03

8.  Repression of CRNDE enhances the anti-tumour activity of CD8 + T cells against oral squamous cell carcinoma through regulating miR-545-5p and TIM-3.

Authors:  Yilong Ai; Siyuan Wu; Hai Gao; Haigang Wei; Zhe Tang; Xia Li; Chen Zou
Journal:  J Cell Mol Med       Date:  2021-11-02       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.